Compare Stocks

Back to Screener

Popular Stock Comparisons

Explore popular stock comparison combinations in the Indian stock market to analyze stock performance, share price, and company financial position for better investment decisions.

Select Stocks to Compare

Add or remove up to 5 stocks to perform stock analysis, comparing market price, stock performance, and financial statements for informed decisions.

Stock Comparison Charts

Metric
Dr. Reddy's Laboratories Limited

Healthcare

Drug Manufacturers - Specialty & Generic
N/A

Healthcare

Drug Manufacturers - Specialty & Generic
Ipca Laboratories Limited

Healthcare

Drug Manufacturers - Specialty & Generic
Strides Pharma Science Limited

Healthcare

Drug Manufacturers - Specialty & Generic
Stock Details
Current Price 1320.9 537.3 1343.8 830.7
Previous Close 1325.3 542.7 1354.4 826.8
Open 1318.9 536.0 1354.0 808.9
Day Low 1302.1 535.2 1339.0 808.9
Day High 1323.0 548.05 1372.4 851.2
Market Cap 1099270193152.0 82261704704.0 345521913856.0 76559556608.0
P/E Ratio 19.51 23.8 46.15 18.85
Forward P/E 3.85 19.39 28.08 12.91
Earnings Per Share 67.72 22.58 29.12 44.07
Dividend Yield (%) 0.6 N/A 0.3 0.3
Beta 0.39 N/A 0.24 0.55
EBITDA 88840003584.0 4606130176.0 17261400064.0 8028120064.0
Book Value 400.7 198.98 273.55 276.93
Debt to Equity 13.87 2.88 16.25 72.67
ROCE (%) N/A N/A N/A N/A
ROE (%) N/A N/A N/A N/A
Face Value N/A N/A N/A N/A
Price to Book 3.3 2.7 4.91 3.0
Performance
1Y Return (%) 943.94 -3184.3 2034.83 -1266.97
About Company
Founded Year N/A N/A N/A N/A
Employees 27811 N/A N/A N/A
Website Live Website of DRREDDY Live Website of AKUMS Live Website of IPCALAB Live Website of STAR

Company Overviews & Financial Position

Review detailed company profiles, including business summaries and key insights into their balance sheet and company financial position to aid in buying or selling decisions.

Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. It also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

N/A

Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. It offers dosage forms, such as tablets, hard and soft gelatin capsules, liquid orals, sachets, vials, ampoules, form fill seals, topical preparations, eye drops, dry powder injections, rotacaps and gummies, and others. The company operates as pharmaceutical contract development and manufacturing company. It also sells branded pharmaceutical formulations. The company was incorporated in 2004 and is based in Delhi, India.

Ipca Laboratories Limited

Ipca Laboratories Limited, a pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, CIS, and Australasia. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company also provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, hematology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. It also exports its products worldwide. The company was incorporated in 1949 and is based in Mumbai, India.

Strides Pharma Science Limited

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.

You May Be Interested In